王清

王清 (senior executive) discloses dealings in 立方制药 to SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 21 November 2022 and the latest from 24 February 2023.

Sales make up the whole of the open-market record (2 sales, €165k). So far in 2023, the count stands at no purchases and 1 sale.

Most recently, on 24 February 2023, the filings show an open-market sale worth €56k in 立方制药. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.